Granahan Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-348,473
| Closed | -$3.14M | – | 194 |
|
|
2021
Q3 | $3.14M | Buy |
348,473
+117,129
| +51% | +$1.06M | 0.06% | 174 |
|
|
2021
Q2 | $2.77M | Buy |
231,344
+12,876
| +6% | +$154K | 0.05% | 174 |
|
|
2021
Q1 | $2.74M | Sell |
218,468
-39,508
| -15% | -$495K | 0.06% | 163 |
|
|
2020
Q4 | $4.03M | Buy |
257,976
+144,588
| +128% | +$2.26M | 0.09% | 144 |
|
|
2020
Q3 | $1.07M | Sell |
113,388
-10,563
| -9% | -$99.9K | 0.04% | 169 |
|
|
2020
Q2 | $1.11M | Buy |
123,951
+22,853
| +23% | +$205K | 0.04% | 167 |
|
|
2020
Q1 | $644K | Sell |
101,098
-1,537
| -1% | -$9.79K | 0.03% | 170 |
|
|
2019
Q4 | $859K | Buy |
102,635
+1,016
| +1% | +$8.5K | 0.04% | 162 |
|
|
2019
Q3 | $920K | Buy |
101,619
+7,370
| +8% | +$66.7K | 0.05% | 158 |
|
|
2019
Q2 | $1.02M | Sell |
94,249
-2,652
| -3% | -$28.6K | 0.05% | 162 |
|
|
2019
Q1 | $924K | Sell |
96,901
-7,116
| -7% | -$67.9K | 0.05% | 173 |
|
|
2018
Q4 | $1.19M | Sell |
104,017
-39,250
| -27% | -$451K | 0.08% | 158 |
|
|
2018
Q3 | $2.43M | Buy |
143,267
+1,919
| +1% | +$32.5K | 0.13% | 139 |
|
|
2018
Q2 | $2.01M | Buy |
141,348
+11,993
| +9% | +$170K | 0.12% | 164 |
|
|
2018
Q1 | $2.46M | Sell |
129,355
-26,349
| -17% | -$501K | 0.18% | 139 |
|
|
2017
Q4 | $2.55M | Sell |
155,704
-309,386
| -67% | -$5.07M | 0.2% | 131 |
|
|
2017
Q3 | $6.98M | Sell |
465,090
-241,769
| -34% | -$3.63M | 0.58% | 65 |
|
|
2017
Q2 | $6.22M | Sell |
706,859
-326,000
| -32% | -$2.87M | 0.57% | 64 |
|
|
2017
Q1 | $5.37M | Buy |
1,032,859
+794,508
| +333% | +$4.13M | 0.54% | 68 |
|
|
2016
Q4 | $727K | Buy |
+238,351
| New | +$727K | 0.03% | 181 |
|
|
2015
Q2 | – | Sell |
-95,400
| Closed | -$1.5M | – | 240 |
|
|
2015
Q1 | $1.5M | Buy |
+95,400
| New | +$1.5M | 0.04% | 219 |
|